Advanced search
Publication Cover
Postgraduate Medicine Volume 99, 1996 - Issue 4
Submit an article Journal homepage
3
Views
17
CrossRef citations to date
0
Altmetric
HYPERTENSION AND COSTS

The costs of treating hypertension

What are the long-term realities of cost containment and pharmacoeconomics?

William J. ElliottView further author information
, MD PhD
Pages 241-252 | Published online: 05 Dec 2017

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

C. Yosefy, G. M. Ginsberg, D. Dicker, J. R. Viskoper, T. H. Tulchinsky, E. Leibovitz & D. Gavish. (2003) Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program - initial cost utility analysis. Blood Pressure 12:4, pages 225-231.
Read now

Articles from other publishers (16)

Armando Arredondo, Emanuel Orozco, Jaqueline Alcalde-Rabanal, Juan Navarro & Alejandra Azar. (2018) Retos sobre la carga epidemiológica y económica para diabetes e hipertensión en México. Revista de Saúde Pública 52, pages 23.
Crossref
M Twagirumukiza & L M Van Bortel. (2010) Management of hypertension at the community level in Sub-Saharan Africa (SSA): towards a rational use of available resources. Journal of Human Hypertension 25:1, pages 47-56.
Crossref
Marc Twagirumukiza, Lieven Annemans, Jan G. Kips, Emile Bienvenu & Luc M. Van Bortel. (2010) Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO’s model list of essential medicines. Tropical Medicine & International Health 15:3, pages 350-361.
Crossref
Luca Degli Esposti & Giorgia Valpiani. (2004) Pharmacoeconomic Burden of Undertreating Hypertension. PharmacoEconomics 22:14, pages 907-928.
Crossref
Wayne N. Burton, Chin-Yu Chen, Daniel J. Conti, Alyssa B. Schultz & Dee W. Edington. (2003) Measuring the Relationship Between Employees’ Health Risk Factors and Corporate Pharmaceutical Expenditures. Journal of Occupational and Environmental Medicine 45:8, pages 793-802.
Crossref
Ellen M. Schellhase & Anne K. Hardin. (2017) Development and Implementation of a Tablet Splitting Education Program in a Veterans Affairs Medical Center. Hospital Pharmacy 38:5, pages 453-457.
Crossref
William J. Elliott. (2007) The Economic Impact of Hypertension. The Journal of Clinical Hypertension 5:3, pages 3-13.
Crossref
J. Honorato. (2003) Farmacoeconomía y tratamiento de la hipertensión arterial. Hipertensión y Riesgo Vascular 20:5, pages 193-194.
Crossref
Mark P. Okamoto & Randy K. Nakahiro. (2012) Pharmacoeconomic Evaluation of a Pharmacist‐Managed Hypertension Clinic. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 21:11, pages 1337-1344.
Crossref
Ettore Ambrosioni. (2001) Pharmacoeconomics of Hypertension Management. PharmacoEconomics 19:4, pages 337-347.
Crossref
Thomas W. Wilson & Clarence E. Grim. 2008. The Cambridge World History of Food. The Cambridge World History of Food 848 856 .
. 2008. The Cambridge World History of Food. The Cambridge World History of Food 739 740 .
C WhitcombG EnzmannHA Pershadsingh, R Johnson, V Ciuryla & E Reisin. (2000) A COMPARISON OF NISOLDIPINE ER AND AMLODIPINE FOR THE TREATMENT OF MILD TO MODERATE HYPERTENSION. International Journal of Clinical Practice 54:8, pages 509-513.
Crossref
Devidas Menon & Lila Assiff. (2000) The Burden of Illness of Employees on United States Employers: A Critical Review of the Literature. Drug Information Journal 34:1, pages 47-58.
Crossref
Joseph T. McDevitt, Andrea H. Gurst & Yinshuo Chen. (2012) Accuracy of Tablet Splitting. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 18:1, pages 193-197.
Crossref
Ralph E. Small, Susan B. Freeman‐Arnold, Jean‐Venable R. Goode & Michael A. Pyles. (2012) Evaluation of the Total Cost of Treating Elderly Hypertensive Patients with ACE Inhibitors: A Comparison of Older and Newer Agents. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 17:5, pages 1011-1016.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.